Thirty-day hospital readmissions in systemic lupus erythematosus: Predictors and hospital- and state-level variation

Arthritis and Rheumatology

Volumn 66, Issue 10, 2014, Pages 2828-2836

  Yazdany, Jinoos ^a   Marafino, Ben J ^a   Dean, Mitzi L ^a   Bardach, Naomi S ^a   Duseja, Reena ^a   Ward, Michael M ^b   Dudley, R Adams ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CASE MIX; CHARLSON COMORBIDITY INDEX; DIABETES MELLITUS; FEMALE; GEOGRAPHY; HEART FAILURE; HISPANIC; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAID; MEDICARE; PNEUMONIA; POPULATION RESEARCH; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; ADOLESCENT; FACTUAL DATABASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84908388886     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38768     Document Type: Article

References (32)

1. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM,. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007; 56: 2092-4.
2. Panopalis P, Yazdany J, Gillis JZ, Julian L, Trupin L, Hersh AO, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 1788-95.
3. Elixhauser A, Steiner C,. Readmissions to US hospitals by diagnosis, 2010. Healthcare Cost and Utilization Project (HCUP) statistical brief #153. Rockville (MD): Agency for Healthcare Research and Quality; April 2013. URL: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb153.pdf.
4. Yazdany J, Tonner C, Trupin L, Panopalis P, Gillis JZ, Hersh AO, et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther 2010; 12: R84.
5. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J,. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 2010; 62: 993-1001.
6. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH,. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum 2010; 40: 193-200.
7. Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, et al. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. J Gen Intern Med 2012; 27: 1326-33.
8. Yazdany J, Feldman CH, Liu J, Ward MM, Fischer MA, Costenbader KH,. Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res 2014; 66: 617-24.
9. Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013; 309: 355-63.
10. Thorburn CM, Ward MM,. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2519-23.
11. Ward MM,. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals? J Rheumatol 2002; 29: 1198-206.
12. Krishnan E,. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1770-4.
13. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH,. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus 2003; 12: 672-6.
14. Klabunde CN, Potosky AL, Legler JM, Warren JL,. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258-67.
15. Ward MM,. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. J Rheumatol 2000; 27: 1408-13.
16. Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH,. Veteran's Affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol 2007; 60: 397-409.
17. Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013; 309: 355-63.
18. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008; 58: 15-25.
19. Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort [published erratum appears in Arthritis Rheum 2001;45:306). Arthritis Rheum 2001; 45: 191-202.
20. Demas KL, Costenbader KH,. Disparities in lupus care and outcomes. Curr Opin Rheumatol 2009; 21: 102-9.
21. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcon GS, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum 2013; 65: 753-63.
22. Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797-806.
23. Podulka J, Barrett M, Jiang HJ, Steiner C,. 30-day readmissions following hospitalizations for chronic vs. acute conditions, 2008. Healthcare Cost and Utilization Project (HCUP) statistical brief #127. Rockville (MD): Agency for Healthcare Research and Quality; February 2013. URL: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb127.jsp.
24. Hersh AO, Trupin L, Yazdany J, Panopalis P, Julian L, Katz P, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 1152-9.
25. Levy M, Montes de Oca M, Claude-Babron M,. Unfavorable outcomes (end-stage renal failure/death) in childhood onset systemic lupus erythematosus: a multicenter study in Paris and its environs. Clin Exp Rheumatol 1994; 12 Suppl 10: S63-8.
26. Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1481-90.
27. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
28. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T,. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290-5.
29. Jencks SF, Williams MV, Coleman EA,. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418-28.
30. Coleman EA, Parry C, Chalmers S, Min SJ,. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006; 166: 1822-8.
31. Isenberg DA, Ramsey-Goldman R, Gladman D, Hanly JG,. The Systemic Lupus International Collaborating Clinics (SLICC) group-it was 20 years ago today [published erratum appears in Lupus 2012;21:113]. Lupus 2011; 20: 1426-32.
32. Moores KG, Sathe NA,. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data. Vaccine 2013; 31 Suppl 10: K62-73.